Teleflex Inc (TFX)
209.07
+2.43
(+1.18%)
USD |
NYSE |
May 31, 16:00
209.13
+0.06
(+0.03%)
Pre-Market: 20:00
Teleflex Enterprise Value: 11.37B for May 31, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 31, 2024 | 11.37B |
| May 30, 2024 | 11.25B |
| May 29, 2024 | 11.06B |
| May 28, 2024 | 11.16B |
| May 24, 2024 | 11.24B |
| May 23, 2024 | 11.25B |
| May 22, 2024 | 11.56B |
| May 21, 2024 | 11.55B |
| May 20, 2024 | 11.63B |
| May 17, 2024 | 11.77B |
| May 16, 2024 | 11.82B |
| May 15, 2024 | 11.87B |
| May 14, 2024 | 11.54B |
| May 13, 2024 | 11.29B |
| May 10, 2024 | 11.13B |
| May 09, 2024 | 11.16B |
| May 08, 2024 | 10.96B |
| May 07, 2024 | 11.01B |
| May 06, 2024 | 10.99B |
| May 03, 2024 | 11.08B |
| May 02, 2024 | 10.88B |
| May 01, 2024 | 11.49B |
| April 30, 2024 | 11.35B |
| April 29, 2024 | 11.34B |
| April 26, 2024 | 11.26B |
| Date | Value |
|---|---|
| April 25, 2024 | 11.26B |
| April 24, 2024 | 11.47B |
| April 23, 2024 | 11.46B |
| April 22, 2024 | 11.28B |
| April 19, 2024 | 11.25B |
| April 18, 2024 | 11.29B |
| April 17, 2024 | 11.33B |
| April 16, 2024 | 11.42B |
| April 15, 2024 | 11.44B |
| April 12, 2024 | 11.62B |
| April 11, 2024 | 11.76B |
| April 10, 2024 | 11.80B |
| April 09, 2024 | 12.06B |
| April 08, 2024 | 11.74B |
| April 05, 2024 | 11.73B |
| April 04, 2024 | 11.50B |
| April 03, 2024 | 11.64B |
| April 02, 2024 | 11.76B |
| April 01, 2024 | 12.02B |
| March 31, 2024 | 12.17B |
| March 28, 2024 | 12.25B |
| March 27, 2024 | 12.14B |
| March 26, 2024 | 11.78B |
| March 25, 2024 | 11.94B |
| March 22, 2024 | 12.00B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
9.586B
Minimum
Oct 27 2023
22.80B
Maximum
Apr 28 2021
16.03B
Average
16.94B
Median
Enterprise Value Benchmarks
| ResMed Inc | 31.08B |
| Stryker Corp | 140.40B |
| Boston Scientific Corp | 119.63B |
| Perspective Therapeutics Inc | 680.29M |
| Xtant Medical Holdings Inc | 116.30M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 15.29M |
| Revenue (Quarterly) | 737.85M |
| Total Expenses (Quarterly) | 739.98M |
| EPS Diluted (Quarterly) | 0.32 |
| Gross Profit Margin (Quarterly) | 56.40% |
| Profit Margin (Quarterly) | 2.07% |
| Earnings Yield | 2.98% |
| Operating Earnings Yield | 4.48% |
| Normalized Earnings Yield | 3.44 |